Below are highlights from Benzinga's daily coverage of microcap securities. Benzinga provides comprehensive, objective, and conflict-free coverage of the microcap sector in real-time at BenzingaSmallCap.com.
BSD Medical
BSD Medical BSDM, a Salt Lake City, UT maker of systems to treat cancer and benign diseases using heat therapy delivered using focused radio frequency and microwave energy, announced they have received Humanitarian Device Exemption marketing approval from the FDA for the BSD-2000 Hyperthermia System.
The BSD-2000 is approved for use in conjunction with radiation therapy for the treatment of cervical cancer patients who normally would be treated with combined chemotherapy and radiation but are ineligible for chemotherapy due to patient related factors.
An HDE approval is obtained after a company has demonstrated the product's safety and probable benefit for the treatment of a disease affecting fewer than 4,000 people in the United States every year.
BSD shares traded at 10 times the average daily volume on Monday in a range of $2.82 to $3.22 and closed at $3.06, a gain of 16% on the day.
Adeona Pharmaceuticals
Adeona Pharmaceuticals AEN, Ann Arbor, MI based biotech company specializing in the development of drugs that involve the central nervous system, announced today a collaboration with privately held Intrexon.
Under the agreement, Adeona intends to develop and commercialize a DNA-based therapeutic using Intrexon's UltraVector platform and RheoSwitch Therapeutic System for the treatment of pulmonary arterial hypertension.
Adeona will utilize Intrexon's advanced transgene engineering platform for the controlled, precise and continuous in vivo cellular production of prostaglandin synthase (PGIS), a specific effector enzyme that regulates the production of prostacyclin.
Adeona shares traded at 22 times the average daily volume on Monday in a range of $0.62 to $0.94 and closed at $0.76, a gain of 42% for the day.
EDGAR Online
EDGAR Online EDGR, the Rockville, MD distributor of financial data, including SEC filings, announced it has increased revenue growth guidance to be in excess of 35 percent in 2011 over 2010. The company continues to target annual revenue growth in excess of 25 percent in 2012 and 2013.
Shares of EDGAR online traded Monday in a range of $0.42 to $0.51 and closed at $0.43, up 13% on 6 times average daily volume.
Seven Arts Entertainment
Shares of Seven Arts Entertainment SAPX, London-based independent motion picture producer and distributor, gained 43% today on 12 times average daily volume.
Seven Arts shares traded in a range of $0.43 to $0.63 and ended the day at $0.59, up $0.18.
Calls by Benzinga into both the London and Los Angeles offices of the company were not answered and there is no news directly associated with this price move.
To get information like this on a streaming basis during the trading day, try a 100% free trial to BenzingaSmallCap.com.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in